Merck |
January2020Merck buy a license of Makya |
UCB |
January2020Iktos initiate a research collaboration with UCB across three different projects. In September 2020, UCB buy a license of Spaya |
Pfizer |
August2020Pfizer buy a license of Kaya (Python version of Makya) |
Alkermes |
July2020Alkermes buy a license of Kaya (Python version of Makya) |
Blueprint |
June2020Iktos initiates a research |
Lundbeck |
July2020Lundbeck buy a license of Kaya (Python version of Makya) |
LEO Pharma |
February2020Iktos initiates a research |
Awards
March
2018
Winner of the French
“Worldwide Innovation Challenge Phase 2”.
Iktos will benefit from non-dilutive funding from Bpifrance for 900k€
October
2017
Iktos wins the Innov’Up Proto challenge,
sponsored by the Paris region,
and will get a 100k€
non-dilutive funding.
March
2017
Iktos is labelled by
Cap Digital for
its application to
CMI and CIN challenges